CNVY insider filings
Convey Health Solutions Holdings, Inc. — 23 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-10-12. Screen CNVY transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CNVY between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Convey Health Solutions Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-10-12 | 4 | Steele John E. — EVP, Technology | Disposition to issuer (D): 182,395 @ $10.50 · Disposition to issuer (D): 161,214 (derivative) · Disposition to issuer (D): 299,394 (derivative) · Disposition to issuer (D): 111,607 (derivative) · Disposition to issuer (D): 30,692 (derivative) · Disposition to issuer (D): 162,749 (derivative) | EDGAR |
| 2022-10-12 | 4 | Whitmer William Carl — Director | Disposition to issuer (D): 25,200 @ $10.50 · Disposition to issuer (D): 69,300 (derivative) · Disposition to issuer (D): 27,125 (derivative) | EDGAR |
| 2022-10-12 | 4 | Pichardo Susana — SVP, Accounting | Disposition to issuer (D): 47,765 (derivative) · Disposition to issuer (D): 47,468 (derivative) | EDGAR |
| 2022-10-12 | 4 | Stern Kyle — Mng Partner, HealthScape & EVP | Disposition to issuer (D): 154,191 @ $10.50 · Disposition to issuer (D): 161,214 (derivative) · Disposition to issuer (D): 299,394 (derivative) · Disposition to issuer (D): 111,607 (derivative) · Disposition to issuer (D): 30,692 (derivative) · Disposition to issuer (D): 162,749 (derivative) | EDGAR |
| 2022-10-12 | 4 | Mansukani Sharad — Director | Disposition to issuer (D): 235,935 (derivative) · Disposition to issuer (D): 438,165 (derivative) · Disposition to issuer (D): 54,250 (derivative) | EDGAR |
| 2022-10-12 | 4 | Campanelli Paul — Director | Disposition to issuer (D): 27,125 (derivative) | EDGAR |
| 2022-10-12 | 4 | Fairbanks Timothy — Chief Financial Officer & EVP | Disposition to issuer (D): 53,287 @ $10.50 · Disposition to issuer (D): 191,066 (derivative) · Disposition to issuer (D): 354,838 (derivative) · Disposition to issuer (D): 219,711 (derivative) | EDGAR |
| 2022-10-12 | 4 | FARRELL STEPHEN C — CHIEF EXECUTIVE OFFICER, Director | Disposition to issuer (D): 163,373 @ $10.50 · Disposition to issuer (D): 525,434 (derivative) · Disposition to issuer (D): 975,806 (derivative) · Disposition to issuer (D): 355,561 (derivative) | EDGAR |
| 2022-09-19 | 4 | Stern Kyle — Mng Partner, HealthScape & EVP | Option exercise (M): 11,161 @ $0 · Tax withholding (F): 3,271 @ $3.97 · Option exercise (M): 2,790 @ $0 · Tax withholding (F): 818 @ $10.50 · Option exercise (M): 11,161 (derivative) @ $0 · Option exercise (M): 2,790 (derivative) @ $0 | EDGAR |
| 2022-09-19 | 4 | Steele John E. — EVP, Technology | Option exercise (M): 11,161 @ $0 · Tax withholding (F): 3,271 @ $3.97 · Option exercise (M): 2,790 @ $0 · Tax withholding (F): 818 @ $10.50 · Option exercise (M): 11,161 (derivative) @ $0 · Option exercise (M): 2,790 (derivative) @ $0 | EDGAR |
| 2022-09-09 | 4 | Pichardo Susana — SVP, Accounting | Option exercise/expiry (X): 41,795 @ $7.94 · Option exercise/expiry (X): 29,856 @ $6.76 · Sale (S): 71,651 @ $10.50 · Option exercise/expiry (X): 41,795 (derivative) @ $0 · Option exercise/expiry (X): 29,856 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | Whitmer William Carl — Director | Grant/award (A): 27,125 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | Steele John E. — EVP, Technology | Grant/award (A): 162,749 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | Pichardo Susana — SVP, Accounting | Grant/award (A): 47,468 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | Stern Kyle — Mng Partner, HealthScape & EVP | Grant/award (A): 162,749 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | Mansukani Sharad — Director | Grant/award (A): 54,250 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | Campanelli Paul — Director | Grant/award (A): 27,125 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | Fairbanks Timothy — Chief Financial Officer & EVP | Grant/award (A): 219,711 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | FARRELL STEPHEN C — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 355,561 (derivative) @ $0 | EDGAR |
| 2021-06-22 | 4 | TPG Group Holdings (SBS) Advisors, Inc. — 10% owner BONDERMAN DAVID — 10% owner COULTER JAMES G — 10% owner | Sale (S): 1,666,667 @ $13.02 | EDGAR |
| 2021-06-21 | 4 | Stern Kyle — Mng Partner, HealthScape & EVP | Purchase (P): 38,760 @ $13.12 | EDGAR |
| 2021-06-21 | 4 | Steele John E. — EVP, Technology | Purchase (P): 38,500 @ $12.94 | EDGAR |
| 2021-06-21 | 4 | FARRELL STEPHEN C — CHIEF EXECUTIVE OFFICER, Director | Purchase (P): 45,000 @ $13 | EDGAR |
Recent 8-K events — Convey Health Solutions Holdings, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2022-10-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-05-10 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-03-23 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-02-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-02-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-01-11 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-01-10 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CNVY returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs